ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO)

CUSIP: 00166B105

Q2 2023 13F Holders as of 30 Jun 2023

Holder snapshot 7 signals
Share change
-1,402,460
Put/Call ratio
13%
SEC-reported price per share
$7.51
Number of holders
74
Value change
-$6,376,897
Number of buys
37
Open additional details 1 more signal available
Number of sells
40
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
129,403,824

Security key

00166B105

Report period

Q2 2023

Institutions

74

Top holders

10

Ownership snapshot

Top reported holders of ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
LSV Associates, LLC
Disclosed value leader
LSV Associates, LLC
Comparable rows
0/15
Latest evidence
20 Jun 2023
3/4/5 13F Highest disclosed value: $61,575,751 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

LSV Associates, LLC has the largest disclosed position value at $61.58M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens LSV Associates, LLC's linked filing trail.
Disclosed position value Top 5
LSV Associates, LLC $61.58M
venBio Partners LLC $43.84M
Vivo Capital, LLC $19.07M
ORBIMED ADVISORS LLC $12.98M
BlackRock Finance, Inc. $7.54M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
LSV Associates, LLC
3/4/5
10%+ Owner
—
denominator unverified
$61,575,751
4,526,963 shares
— 13 Dec 2021
Jack Nielsen
3/4/5
Director, 10%+ Owner
—
denominator unverified
—
20,200 shares
— 20 Jun 2023
venBio Partners LLC
13F
Company
13F
—
denominator unverified
$43,843,661
9,699,925 shares
— 31 Mar 2023
Vivo Capital, LLC
13F
Company
13F
—
denominator unverified
$19,074,617
4,220,048 shares
— 31 Mar 2023
ORBIMED ADVISORS LLC
13F
Company
13F
—
denominator unverified
$12,976,920
2,871,000 shares
— 31 Mar 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$7,542,180
1,668,624 shares
— 31 Mar 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
74
Shares
34,283,564
Rows available
74
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
85
Q2 2023 holders
74
Holder diff
-11
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 value Q2 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .